Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joud H Haidar

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Haematology|March 27, 2003
Signet ring-like light chain myeloma with systemic spreadJoud H Haidar, Ali Bazarbachi, Michel R Nasr, et al.
Journal of Hematotherapy & Stem Cell Research|August 20, 2002
Serum Flt3 ligand variation as a predictive indicator of hematopoietic stem cell mobilizationJoud H Haidar, Ali Bazarbachi, Rami Mahfouz, et al.
European Journal of Haematology|April 16, 2003
Loss of CD20 expression in relapsed lymphomas after rituximab therapyJoud H Haidar, Ali Shamseddine, Ziad Salem, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Haematology|March 27, 2003
Signet ring-like light chain myeloma with systemic spreadJoud H Haidar, Ali Bazarbachi, Michel R Nasr, et al.
Journal of Hematotherapy & Stem Cell Research|August 20, 2002
Serum Flt3 ligand variation as a predictive indicator of hematopoietic stem cell mobilizationJoud H Haidar, Ali Bazarbachi, Rami Mahfouz, et al.
European Journal of Haematology|April 16, 2003
Loss of CD20 expression in relapsed lymphomas after rituximab therapyJoud H Haidar, Ali Shamseddine, Ziad Salem, et al.
Pageof 1